You are here

  • Home
  • Archive
  • Volume 73, Issue 11
  • Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Putrik P, Ramiro S, Kvien TK on behalf of Equity in Clinical Eligibility Criteria for RA treatment Working Group, et al
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?
Annals of the Rheumatic Diseases 2014;73:2010-2021.